Recent articles
2 Marijuana Stocks You Can Buy and Hold for the Next Decade
Lower your investing risk by buying stock in cannabis companies that are already turning a profit.
Why Canopy Growth's Shares Jumped 22.4% This Week
Canopy has had a rough year, but its shares saw a brief jump this week.
Why Liquidia Shares Rose 18.4% on Monday
Optimism by the company regarding a patent ruling is encouraging investors.
Why Invitae Corporation Stock Jumped 23% This Week
The stock had a big climb after its second-quarter report.
2 Cannabis Stocks You Can Buy and Hold for the Next Decade
These two companies are already profitable, and at their current share prices, they're solid long-term buys.
Why Shares of Co-Diagnostics Stock Fell 10% on Tuesday
The stock dropped two days before reporting second-quarter earnings.
Why Shares of Abiomed Rose 18.4% in July
The company's stock rose steadily throughout the month.
Why Shares of Align Technology Rose 18.7% in July
Investors shrugged off a so-so second-quarter report.
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
Consumers turn to these two retailers in recessions to save money.
Why Twist Bioscience's Shares Rose 25.1% in July
Two bits of positive news spurred the stock's rise.
Why Shares of MannKind Corporation Climbed 10.4% on Monday
The company is coming off an FDA approval for its second marketed drug.
2 Biotech Stocks That Could Help Make You a Fortune
These companies have seen triple-digit revenue growth in recent years.
Why Virax Biolabs Stock Plummeted 74% On Friday
The stock had a wild trading day with an initial upswing, followed by a strong downtrend.
Why Shares of Bausch Health Companies Dropped 54.4% This Week
A patent-court loss sent investors scurrying to the exits.
Why Legend Biotech's Shares Jumped 11.8% on Wednesday
Investors, on second glance, might think the company's stock offering is a good idea.
Why Shares of Agenus Inc. Rose 10.1% on Tuesday
The company has a promising colon cancer therapy.
Why Shares of Verve Therapeutics Shot Up 44.9% This Week
The gene-editing company is getting an infusion of cash.
2 Biotech Stocks to Help Recession-Proof Your Portfolio
These companies' shares have outpaced the market and other biotech stocks this year.
Why GlaxoSmithKline Stock Jumped 25% on Thursday
Investors may be warming to the company's spin-off of its consumer healthcare division.
Why Shares of Clene Jumped 11.8% on Monday
The company's lead therapy has shown progress against ALS in preliminary trials.